Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
fatty liver
MeSH D005234 - fatty liver
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008107:
Liver diseases
2 Companies
2 Drugs
$
Success rate
D005234:
Fatty liver
1 Company
1 Drug
$
Success rate
D005235:
Alcoholic fatty liver
0 Companies
0 Drugs
Success rate
D012202:
Reye syndrome
18 Companies
2 Drugs
$
Success rate
D065626:
Non-alcoholic fatty liver disease
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
78
%
7/9
Phase 2
25
%
5/20
Phase 3
63
%
5/8
Approved:
0
Overall Success rate:
12%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Madrigal Pharmaceuticals
Resmetirom
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use